Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Concordia Healthcare Corp. T.CXR.R

Healthcare Biotechnology

TSX:CXR.R - Post Discussion

Concordia Healthcare Corp. > Press release out
View:
Post by 1health on Feb 23, 2016 9:07am

Press release out

The restatements are neutral and immaterial. Short covering due ...
and wait for the results next week 29thfeb. to get another leg up to clean all shorts
Comment by easymoola2003 on Feb 23, 2016 9:11am
Yep...small restatement...thought we were in for a big swoosh... You gotta wonder though, what's the next shoe to drop with that company
Comment by LAMBO on Feb 23, 2016 9:19am
cxr gap up but not high enough Valeant announced it is re-stating its 2014 financial results due to a revenue recognition problem with US$58 million in sales to Philidor, which were recognized at time of delivery to Philidor rather than to the end customer (VRX has in the past stated that the latter was its rule). The cost to 2014 GAAP earnings is 10 cents (on $1.80 in 2014 GAAP earnings). However ...more  
Concordia Healthcare Corp.